13F HOLDINGS REPORT
BROADWOOD CAPITAL INC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0000919574-23-001165
Total Value
$1.20B
Positions
7
Other Managers
1
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MONSTER BEVERAGE CORP NEW | MNST | 4,656,488 | $472.8M | 39.54% |
| 2 | STAAR SURGICAL CO | STAA | 8,783,082 | $426.3M | 35.66% |
| 3 | AXON ENTERPRISE INC | AXON | 760,062 | $126.1M | 10.55% |
| 4 | ISHARES TR | 464287655 | 690,000 | $120.3M | 10.06% |
| 5 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 34,935,485 | $40.9M | 3.42% |
| 6 | ONCOCYTE CORP | 68235C107 | 23,353,697 | $7.5M | 0.63% |
| 7 | AGEX THERAPEUTICS INC | 00848H108 | 2,997,156 | $1.7M | 0.14% |